Inosine Triphosphate Pyrophosphatase and Thiopurine S-Methyltransferase Genotypes Relationship to Azathioprine-Induced Myelosuppression-Reference-Cited by-同舟云学术

Inosine Triphosphate Pyrophosphatase and Thiopurine S-Methyltransferase Genotypes Relationship to Azathioprine-Induced Myelosuppression

Published:2006-01 Issue:1 Volume:4 Page:44-49
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Zelinkova Zuzana,Derijks Luc J.J.,Stokkers Pieter C.F.,Vogels Esther W.M.,van Kampen Antoine H.C.,Curvers Wouter L.,Cohn Danny,van Deventer Sander J.H.,Hommes Daniël W.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference18 articles.

1. The efficacy of azathioprine for the treatment of inflammatory bowel disease;Fraser;Gut,2002

2. Azathioprine and 6-mercaptopurine in Crohn’s disease. A meta-analysis;Pearson;Ann Intern Med,1995

3. A review of immune modifier therapy for inflammatory bowel disease;Sandborn;Am J Gastroenterol,1996

4. Safety of thiopurines in the treatment of inflammatory bowel disease;de Jong;Scand J Gastroenterol Suppl,2003

5. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease;Kirschner;Gastroenterology,1998

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive role of ITPA genetic variants in thiopurine-related myelotoxicity in Crohn’s disease patients;The Pharmacogenomics Journal;2024-06-21

2. The Role of Pharmacogenetics in the Therapeutic Response to Thiopurines in the Treatment of Inflammatory Bowel Disease: A Systematic Review;Journal of Clinical Medicine;2023-10-25

3. Time to incorporate preemptive NUDT15 testing before starting thiopurines in inflammatory bowel disease in Asia and beyond: a review;Expert Review of Clinical Pharmacology;2023-07-03

4. Single-Nucleotide Polymorphisms, c.415C > T (Arg139Cys) and c.416G > A (Arg139His), in the <i>NUDT15</i> Gene Are Associated with Thiopurine-Induced Leukopenia;Biological and Pharmaceutical Bulletin;2023-03-01

5. ITPA polymorphisms do not predict additional risk beyond TPMT and NUDT15 for thiopurine-induced cytopenia in inflammatory bowel disease;Revista de Gastroenterología de México (English Edition);2023-01